Trial Profile
The curative effect of Diquafosol Sodium ophthalmic solution 3% to the diabetic who has the amount fall of tear fluid secretion, and an anterior-epithelium-of-cornea obstacle.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary) ; Eye disorder therapies; Hyaluronic acid
- Indications Diabetic complications
- Focus Therapeutic Use
- 26 Jun 2013 New trial record